RBCC Forms Joint Venture with Cutting-Edge Drug Delivery Company TheraKine

News   Mar 21, 2013

 
RBCC Forms Joint Venture with Cutting-Edge Drug Delivery Company TheraKine
 
 
 

RELATED ARTICLES

Key Cancer-Linked Proteins Thought to be ‘Undruggable’ Until Now

News

A new study published in Nature, conducted by an alliance between industry and academia involving the University of Liverpool, highlights a new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’.

READ MORE

Cocktail Tests on Toxic Waste Called For

News

Urban waterways receive a cocktail of pollutants, sometimes containing high concentrations of medicines like antidepressants. Surprisingly low concentrations of toxic chemicals can change the way some aquatic creatures swim and feed producing some unexpected results.

READ MORE

Sekisui XenoTech Appoints New COO

News

Company hires CRO & pharma veteran, Dr. Darren Warren, as new Chief Operating Officer.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE